Resistin May Be an Independent Predictor of Subclinical Atherosclerosis Formale Smokers

Ying He,Xiao-Jun Bai,Fen-Xia Li,Li-Hong Fan,Jie Ren,Qi Liang,Hong-Bing Li,Ling Bai,Hong-Yan Tian,Fen-Ling Fan,Gang Tian,Ai-Qun Ma,Jinghong Chen
DOI: https://doi.org/10.1080/1354750x.2016.1252953
2016-01-01
Biomarkers
Abstract:Abstract To investigate whether resistin is associated with early atherosclerosis in male smokers. The present study consecutively enrolled 50 male smokers. Their serum resistin contents were detected with enzyme linked immunosorbent assay (ELISA), and subclinical atherosclerosis indices, including carotid inner middle thickness (IMT) and arterial elasticity indices (C1 and C2), were measured. The association between serum resistin levels and IMT, C1 and C2 were respectively evaluated with the Pearson’s correlation coefficient method. The results showed that the serum resistin level had a positive association with IMT (r = 0.307, p = .030), but were both inversely associated with C1 (r = −0.440, p = .001) and C2 (r = −0.381, p = .006). These associations remained significant even after adjustment for cardiovascular confounders. In conclusion, serum resistin concentration was independently associated with early atherosclerosis in male smokers.
What problem does this paper attempt to address?